Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P13
Within normal range
vs 2Y Ago
-4.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-99.34%
Q3 202521.56%
Q2 202531.87%
Q1 2025-5.34%
Q4 202452.66%
Q3 2024-6.43%
Q2 2024-16.10%
Q1 2024-56.62%
Q4 202321.37%
Q3 202310.49%
Q2 202320.87%
Q1 202315.48%
Q4 2022-210.35%
Q3 202261.47%
Q2 2022-363.71%
Q1 202286.24%
Q4 2021-1498.94%
Q3 202181.89%
Q2 202115.87%
Q1 202111.03%
Q4 2020-46.01%
Q3 2020-60.19%
Q2 2020-23.38%
Q1 20200.00%